<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://www.la-ser.com/wordpress/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/3.3.1" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.2.4" -->
<!-- generated-on="February 1, 2012 4:42 pm" -->
<!-- Debug: Total comment count: 0 -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://www.la-ser.com/</loc>
		<lastmod>2011-12-14T17:46:20+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings -->
	<url>
		<loc>http://www.la-ser.com/la-ser-offices/</loc>
		<lastmod>2012-02-01T16:41:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/careers/</loc>
		<lastmod>2012-01-27T12:29:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/la-ser-contact/</loc>
		<lastmod>2011-12-23T15:21:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/events-2/</loc>
		<lastmod>2011-11-17T13:03:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/events-2/news/</loc>
		<lastmod>2011-11-09T15:12:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/core-scientific-team/</loc>
		<lastmod>2011-03-22T11:44:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/publications/</loc>
		<lastmod>2011-02-25T12:11:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/our-services/risk-assessment-management/</loc>
		<lastmod>2011-02-11T10:50:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/our-services/medicines-values-assessment/</loc>
		<lastmod>2011-02-11T10:49:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/our-services/effectiveness-relative-effectiveness-studies/</loc>
		<lastmod>2011-02-11T10:48:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/our-services/</loc>
		<lastmod>2011-02-11T10:47:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/</loc>
		<lastmod>2011-02-11T10:46:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/experience/</loc>
		<lastmod>2011-02-03T17:42:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/core-scientific-team/ralph-moussali-msc/</loc>
		<lastmod>2011-02-03T14:26:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/locations/</loc>
		<lastmod>2011-01-27T19:46:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/core-scientific-team/tam-dang-tan/</loc>
		<lastmod>2011-01-27T18:45:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/core-scientific-team/michel-rossignol/</loc>
		<lastmod>2011-01-27T18:44:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/core-scientific-team/mary-new/</loc>
		<lastmod>2011-01-27T18:43:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/core-scientific-team/lucien-abenhaim/</loc>
		<lastmod>2011-01-27T18:42:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/core-scientific-team/lamiae-grimaldi-bensouda/</loc>
		<lastmod>2011-01-27T18:41:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/core-scientific-team/eric-mertz/</loc>
		<lastmod>2011-01-27T18:39:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/core-scientific-team/bernard-avouac/</loc>
		<lastmod>2011-01-27T18:39:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/core-scientific-team/andre-haik/</loc>
		<lastmod>2011-01-27T18:38:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/investigators/</loc>
		<lastmod>2011-01-27T18:30:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.la-ser.com/about-la-ser/company-overview/</loc>
		<lastmod>2011-01-27T17:46:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 878: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/risk-stratification-by-level-of-care-for-comparing-bloodstream-infection-rates-in-neonatal-intensive-care-units/</loc>
		<lastmod>2011-01-20T12:01:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 876: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/variation-in-infection-incidence-between-neonatal-intensive-care-units-can-depend-on-the-measures-used/</loc>
		<lastmod>2011-01-20T12:00:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 874: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/recovery-of-igm-anti-toxoplasma-gondii-in-stored-guthrie-card-blood-spots/</loc>
		<lastmod>2011-01-20T12:00:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 872: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/occupation-and-mental-health-in-a-national-uk-survey/</loc>
		<lastmod>2011-01-20T11:59:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 870: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/longer-term-psychiatric-adjustment-of-children-and-parents-after-meningococcal-disease/</loc>
		<lastmod>2011-01-20T11:58:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 868: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/double-strand-break-dna-repair-genotype-predictive-of-later-mortality-and-cancer-incidence-in-a-cohort-of-non-smokers/</loc>
		<lastmod>2011-01-20T11:58:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 866: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/vitamin-d-receptor-and-calcium-sensing-receptor-polymorphisms-and-the-risk-of-colorectal-cancer-in-european-populations/</loc>
		<lastmod>2011-01-20T11:57:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 864: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/menopausal-hormone-therapy-and-new-onset-diabetes-in-the-french-etude-epidemiologique-de-femmes-de-la-mutuelle-generale-de-leducation-nationale-e3n-cohort/</loc>
		<lastmod>2011-01-20T11:56:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 862: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/glucocorticoide-therapy-in-premature-infants-french-practices-in-2006-article-in-french/</loc>
		<lastmod>2011-01-20T11:55:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 860: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/avoidability-of-adverse-drug-reactions-spontaneously-reported-to-a-french-regional-drug-monitoring-centre/</loc>
		<lastmod>2011-01-20T11:55:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 858: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/drug-dependence-associated-with-triptans-and-ergot-derivatives-a-casenon-case-study/</loc>
		<lastmod>2011-01-20T11:54:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 856: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/the-cadeus-study-burden-of-nonsteroidal-anti-inflammatory-drug-nsaid-utilization-for-musculoskeletal-disorders-in-blue-collar-workers/</loc>
		<lastmod>2011-01-20T11:53:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 851: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/characteristics-of-subjects-self-reporting-arthritis-in-a-population-health-survey-distinguishing-between-types-of-arthritis/</loc>
		<lastmod>2011-01-20T11:53:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 853: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/epidemiology-of-low-back-pain-whats-new/</loc>
		<lastmod>2011-01-20T11:52:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 845: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/determinants-of-delays-in-treatment-initiation-in-children-and-adolescents-diagnosed-with-leukemia-or-lymphoma-in-canada/</loc>
		<lastmod>2011-01-18T22:25:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 843: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/does-general-practice-reduce-health-inequalities-analysis-of-quality-and-outcomes-framework-data/</loc>
		<lastmod>2011-01-18T22:24:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 841: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/a-review-of-the-public-health-impact-of-the-quality-and-outcomes-framework/</loc>
		<lastmod>2011-01-18T22:24:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 839: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/second-hand-smoke-cotinine-levels-and-risk-of-circulatory-mortality-in-a-large-cohort-study-of-never-smokers/</loc>
		<lastmod>2011-01-18T22:23:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 837: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/variation-in-genes-coding-for-amp-activated-protein-kinase-ampk-and-breast-cancer-risk-in-the-european-prospective-investigation-on-cancer-epic/</loc>
		<lastmod>2011-01-18T22:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 835: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/serum-25oh-vitamin-d-and-risk-of-breast-cancer-a-nested-case-control-study-from-the-french-e3n-cohort/</loc>
		<lastmod>2011-01-18T22:20:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 833: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/recommendations-for-an-update-of-2003-european-regulatory-requirements-for-registration-of-drugs-to-be-used-in-the-treatment-of-ra/</loc>
		<lastmod>2011-01-18T22:19:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 831: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/low-pretreatment-total-testosterone-3-ngml-predicts-extraprostatic-disease-in-prostatectomy-specimens-from-patients-with-preoperative-localized-prostate-cancer/</loc>
		<lastmod>2011-01-18T22:18:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 829: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/menopausal-hormone-therapy-and-risk-of-endometrial-carcinoma-among-postmenopausal-women-in-the-european-prospective-investigation-into-cancer-and-nutrition/</loc>
		<lastmod>2011-01-18T22:17:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 827: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/serum-cholesterol-level-use-of-a-cholesterol-lowering-drug-and-breast-cancer-results-from-the-prospective-e3n-cohort/</loc>
		<lastmod>2011-01-18T22:11:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 825: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/characteristics-and-determinants-of-initiation-of-premenopausal-use-of-oral-progestagens-in-the-french-e3n-cohort-article-in-french/</loc>
		<lastmod>2011-01-18T22:10:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 823: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/postmenopausal-hormone-therapy-and-asthma-onset-in-the-e3n-cohort/</loc>
		<lastmod>2011-01-18T22:08:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 820: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/820/</loc>
		<lastmod>2011-01-18T22:06:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 818: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/clinical-features-and-risk-factors-for-upper-gastrointestinal-bleeding-in-children-a-case-crossover-study/</loc>
		<lastmod>2011-01-18T22:01:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 816: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/agreement-between-patients-self-report-and-physicians-prescriptions-on-cardiovascular-drug-exposure-the-pgrx-database-experience/</loc>
		<lastmod>2011-01-18T21:59:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 814: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/the-international-study-of-insulin-and-cancer/</loc>
		<lastmod>2011-01-18T21:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 812: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/occupation-and-risk-of-lymphoma-a-multicentre-prospective-cohort-study-epic/</loc>
		<lastmod>2011-01-18T21:57:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 810: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/joint-effects-of-dietary-vitamin-d-and-sun-exposure-on-breast-cancer-risk-results-from-the-french-e3n-cohort/</loc>
		<lastmod>2011-01-18T21:56:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 808: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/menopausal-hormone-therapy-and-breast-cancer-risk-impact-of-different-treatments-the-european-prospective-investigation-into-cancer-and-nutrition/</loc>
		<lastmod>2011-01-18T21:55:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 806: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/snp-rs6457327-in-the-mhc-region-on-chromosome-6p-is-predictive-of-the-transformation-of-follicular-lymphoma/</loc>
		<lastmod>2011-01-18T21:54:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 803: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/menopausal-hormone-therapy-and-the-risk-of-osteoporotic-fractures-results-of-the-e3n-study/</loc>
		<lastmod>2011-01-18T21:53:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 801: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/anthropometrical-measures-and-breast-cancer-risk-by-menopausal-status-and-hormone-receptor-status-results-from-the-e3n-cohort/</loc>
		<lastmod>2011-01-18T21:52:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 799: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/benchmarking-clinical-management-of-spinal-and-non-spinal-disorders-using-quality-of-life-results-from-the-epi3-laser-survey-in-primary-care/</loc>
		<lastmod>2011-01-18T21:51:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 797: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/who-seeks-primary-care-for-musculoskeletal-disorders-msds-with-physicians-prescribing-homeopathic-and-other-complementary-medicine-results-from-the-epi3-laser-survey/</loc>
		<lastmod>2011-01-18T21:50:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 794: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/guillain-barre-syndrome-influenzalike-illnesses-and-vaccination-of-influenza-during-seasons-with-and-without-circulating-ah1n1-viruses/</loc>
		<lastmod>2011-01-18T21:50:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 550: Comments: 0 of 0 = 0 points -->
	<url>
		<loc>http://www.la-ser.com/cancer-mortality-study-among-french-cement-production-workers/</loc>
		<lastmod>2011-01-18T20:53:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: End Postings -->
<!-- Debug: Start Custom Pages -->
<!-- Debug: End Custom Pages -->
<!-- Debug: Start additional URLs -->
<!-- Debug: End additional URLs -->
</urlset>
